Charles Berg - DaVita HealthCare Independent Director
| DVA Stock | USD 126.11 1.53 1.20% |
Director
Mr. Charles G. Berg is Director of DaVita HealthCare Partners Inc. Mr. Berg was one of our directors since March 2007, and from November 2016 until December 2017, also served as executive chair of our integrated healthcare business, DaVita Medical Group . On March 25, 2019, Mr. Berg joined the board of directors of TurnKey Health, an Enclara Healthcare company, serving health plans, provider organizations and their members who experience a serious or advanced illness. From 2008 to 2013, Mr. Berg served as executive chairman of WellCare Health Plans, Inc., a provider of managed care services for governmentsponsored healthcare programs. Mr. Berg served as nonexecutive chairman of the board of directors of WellCare from January 2011 until his retirement in May 2013. From January 2007 to April 2009, Mr. Berg was a senior advisor to Welsh, Carson, Anderson Stowe, a private equity firm. From April 1998 to July 2004, Mr. Berg held various executive positions, including executive vice presidentmedical delivery, president and chief operating officer with Oxford Health Plans, Inc., a health benefit plan provider. He was the chief executive officer when Oxford was acquired by UnitedHealth Group. He then became an executive of UnitedHealth Group and was primarily responsible for integrating the Oxford business. Mr. Berg currently serves as a member of the Operating Council Senior Advisory Board of Consonance Capital Partners, a private equity firm, and the board of directors of Justworks, Inc., a private human resources and payment company. Mr. Berg is an experienced business leader with significant experience in the healthcare industry and brings an understanding of the operational, financial and regulatory aspects of our industry and business. since 2016.
| Age | 63 |
| Tenure | 8 years |
| Address | 2000 16th Street, Denver, CO, United States, 80202 |
| Phone | 720 631 2100 |
| Web | https://www.davita.com |
DaVita HealthCare Management Efficiency
The company has Return on Asset of 0.0592 % which means that on every $100 spent on assets, it made $0.0592 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.3853 %, implying that it generated $0.3853 on every 100 dollars invested. DaVita HealthCare's management efficiency ratios could be used to measure how well DaVita HealthCare manages its routine affairs as well as how well it operates its assets and liabilities. At present, DaVita HealthCare's Return On Tangible Assets are projected to slightly decrease based on the last few years of reporting. The current year's Return On Capital Employed is expected to grow to 0.15, whereas Return On Assets are forecasted to decline to 0.04. At present, DaVita HealthCare's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Return On Tangible Assets is expected to grow to 0.07, whereas Total Assets are forecasted to decline to about 10.6 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Cheryl Scott | Evolent Health | 70 | |
| Allen Moseley | Streamline Health Solutions | 46 | |
| Linda Rebrovick | HealthStream | 62 | |
| David Ralph | Simulations Plus | 68 | |
| Martiny Harris | HealthStream | 59 | |
| Norman Payson | Evolent Health | 69 | |
| Michael DAmato | Evolent Health | 66 | |
| Kim Keck | Evolent Health | 56 | |
| Deborah Tate | HealthStream | 61 | |
| Michael Kaplan | Streamline Health Solutions | 50 | |
| Matthew Hobart | Evolent Health | 47 | |
| Jeffrey McLaren | HealthStream | 51 | |
| Kenan Lucas | Streamline Health Solutions | 33 | |
| John Paglia | Simulations Plus | 48 | |
| Dale Polley | HealthStream | 67 | |
| Michael Kirshbaum | Evolent Health | 39 | |
| Frank Gordon | HealthStream | 55 | |
| Michael Valentine | Streamline Health Solutions | 47 | |
| Thompson Dent | HealthStream | 68 | |
| Diane Patrick | Agiliti | 69 | |
| Thaddeus Grasela | Simulations Plus | 61 | |
Management Performance
| Return On Equity | 0.39 | ||||
| Return On Asset | 0.0592 |
DaVita HealthCare Leadership Team
Elected by the shareholders, the DaVita HealthCare's board of directors comprises two types of representatives: DaVita HealthCare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DaVita. The board's role is to monitor DaVita HealthCare's management team and ensure that shareholders' interests are well served. DaVita HealthCare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DaVita HealthCare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Hearty, Chief Compliance Officer | ||
| Shawn Guertin, Director | ||
| Javier Rodriguez, Chief Executive Officer, Director | ||
| Paula Price, Independent Director | ||
| James Hilger, Interim CFO and Chief Accounting Officer | ||
| Paul Diaz, Independent Director | ||
| Misha Palecek, Chief Business | ||
| Christopher Berry, Group Officer | ||
| Jeffrey Giullian, Chief Care | ||
| Robert Lang, President International Business | ||
| John Nehra, Independent Director | ||
| Peter Grauer, Lead Independent Director | ||
| Phyllis Yale, Independent Director | ||
| Craig Samitt, Executive Vice President; CEO of HealthCare Partners | ||
| Robert Margolis, Co-Chairman of the Board | ||
| Joseph Mello, COO of HealthCare Partners | ||
| Jim Gustafson, Vice President - Investor Relations | ||
| John Winstel, Chief Accounting Officer, Group Vice President | ||
| Roger Valine, Independent Director | ||
| Kenneth Smith, Chief Officer | ||
| Gregory Moore, Independent Director | ||
| David Roer, Chief Medical Officer - DaVita Integrated Kidney Care | ||
| FRCPC MD, Chief Operations | ||
| Atul Mathur, Executive Vice President of Global Operations | ||
| Joel Ackerman, Chief Financial Officer, Treasurer | ||
| Kathleen Waters, Chief Legal and Public Affairs Officer | ||
| Pamela Arway, Independent Chairman of the Board | ||
| Michael Staffieri, Chief Operating Officer- DaVita Kidney Care | ||
| Pascal Desroches, Independent Director | ||
| LeAnne Zumwalt, Group Vice President - purchasing and government affairs | ||
| Kenny Gardner, Chief People Officer - DaVita Kidney Care | ||
| Kim Rivera, Chief Legal Officer | ||
| Carol Davidson, Independent Director | ||
| Barbara Desoer, Independent Director | ||
| Dennis Kogod, CEO of International and President of Healthcare Partners | ||
| William Roper, Independent Director | ||
| Mihran Naljayan, Chief Medical Officer - Home Modalities | ||
| Charles Berg, Independent Director | ||
| Jeanine Jiganti, Chief Compliance Officer | ||
| Laura Mildenberger, Chief People Officer - Kidney Care | ||
| MSc MD, Chief International | ||
| Kent Thiry, Chairman, CEO and CEO of Healthcare Partners |
DaVita Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DaVita HealthCare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.39 | ||||
| Return On Asset | 0.0592 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 23.79 B | ||||
| Shares Outstanding | 87.32 M | ||||
| Shares Owned By Insiders | 45.06 % | ||||
| Shares Owned By Institutions | 51.58 % | ||||
| Number Of Shares Shorted | 4.14 M | ||||
| Price To Earning | 11.43 X |
DaVita HealthCare Investors Sentiment
The influence of DaVita HealthCare's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in DaVita. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to DaVita HealthCare's public news can be used to forecast risks associated with an investment in DaVita. The trend in average sentiment can be used to explain how an investor holding DaVita can time the market purely based on public headlines and social activities around DaVita HealthCare Partners. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
DaVita HealthCare's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for DaVita HealthCare's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average DaVita HealthCare's news discussions. The higher the estimated score, the more favorable is the investor's outlook on DaVita HealthCare.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards DaVita HealthCare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, DaVita HealthCare's short interest history, or implied volatility extrapolated from DaVita HealthCare options trading.
Pair Trading with DaVita HealthCare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DaVita HealthCare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DaVita HealthCare will appreciate offsetting losses from the drop in the long position's value.Moving together with DaVita Stock
| 0.95 | ELMD | Electromed | PairCorr |
| 0.84 | ALC | Alcon AG Financial Report 14th of May 2024 | PairCorr |
| 0.89 | BAX | Baxter International Financial Report 25th of April 2024 | PairCorr |
Moving against DaVita Stock
| 0.94 | IVP | Inspire Veterinary | PairCorr |
| 0.82 | TFX | Teleflex Incorporated Financial Report 2nd of May 2024 | PairCorr |
| 0.81 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
| 0.79 | NVST | Envista Holdings Corp Financial Report 1st of May 2024 | PairCorr |
| 0.77 | MMSI | Merit Medical Systems Financial Report 24th of April 2024 | PairCorr |
The ability to find closely correlated positions to DaVita HealthCare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DaVita HealthCare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DaVita HealthCare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DaVita HealthCare Partners to buy it.
The correlation of DaVita HealthCare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DaVita HealthCare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DaVita HealthCare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DaVita HealthCare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for DaVita Stock analysis
When running DaVita HealthCare's price analysis, check to measure DaVita HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DaVita HealthCare is operating at the current time. Most of DaVita HealthCare's value examination focuses on studying past and present price action to predict the probability of DaVita HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DaVita HealthCare's price. Additionally, you may evaluate how the addition of DaVita HealthCare to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is DaVita HealthCare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DaVita HealthCare. If investors know DaVita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DaVita HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.2 | Earnings Share 7.42 | Revenue Per Share 133.717 | Quarterly Revenue Growth 0.078 | Return On Assets 0.0592 |
The market value of DaVita HealthCare is measured differently than its book value, which is the value of DaVita that is recorded on the company's balance sheet. Investors also form their own opinion of DaVita HealthCare's value that differs from its market value or its book value, called intrinsic value, which is DaVita HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DaVita HealthCare's market value can be influenced by many factors that don't directly affect DaVita HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DaVita HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if DaVita HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DaVita HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.